ATE497779T1 - Enzyme zur reduzierung von immunologischem stress - Google Patents

Enzyme zur reduzierung von immunologischem stress

Info

Publication number
ATE497779T1
ATE497779T1 AT06848883T AT06848883T ATE497779T1 AT E497779 T1 ATE497779 T1 AT E497779T1 AT 06848883 T AT06848883 T AT 06848883T AT 06848883 T AT06848883 T AT 06848883T AT E497779 T1 ATE497779 T1 AT E497779T1
Authority
AT
Austria
Prior art keywords
enzymes
immunological stress
reducing immunological
reducing
stress
Prior art date
Application number
AT06848883T
Other languages
English (en)
Inventor
David Anderson
Humg-Yu Hsiao
Lin Liu
Original Assignee
Chemgen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemgen Corp filed Critical Chemgen Corp
Application granted granted Critical
Publication of ATE497779T1 publication Critical patent/ATE497779T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/189—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
    • C12N9/244—Endo-1,3(4)-beta-glucanase (3.2.1.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2477—Hemicellulases not provided in a preceding group
    • C12N9/2488—Mannanases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2477—Hemicellulases not provided in a preceding group
    • C12N9/2488—Mannanases
    • C12N9/2494—Mannan endo-1,4-beta-mannosidase (3.2.1.78), i.e. endo-beta-mannanase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01006—Endo-1,3(4)-beta-glucanase (3.2.1.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01014—Chitinase (3.2.1.14)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01039—Glucan endo-1,3-beta-D-glucosidase (3.2.1.39)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01078—Mannan endo-1,4-beta-mannosidase (3.2.1.78), i.e. endo-beta-mannanase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT06848883T 2005-12-15 2006-12-14 Enzyme zur reduzierung von immunologischem stress ATE497779T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75033905P 2005-12-15 2005-12-15
PCT/US2006/047592 WO2007075343A2 (en) 2005-12-15 2006-12-14 Enzymes for reduced immunological stress

Publications (1)

Publication Number Publication Date
ATE497779T1 true ATE497779T1 (de) 2011-02-15

Family

ID=38218427

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06848883T ATE497779T1 (de) 2005-12-15 2006-12-14 Enzyme zur reduzierung von immunologischem stress

Country Status (35)

Country Link
US (5) US7914782B2 (de)
EP (2) EP2263685A3 (de)
JP (1) JP5189989B2 (de)
KR (2) KR101454032B1 (de)
CN (3) CN105831428B (de)
AR (1) AR057247A1 (de)
AT (1) ATE497779T1 (de)
AU (1) AU2006329927B2 (de)
BR (1) BRPI0620155B1 (de)
CA (1) CA2633066C (de)
CL (1) CL2011000941A1 (de)
CR (1) CR10116A (de)
DE (1) DE602006020074D1 (de)
DK (1) DK1973561T3 (de)
EC (1) ECSP088578A (de)
ES (1) ES2361819T3 (de)
GT (1) GT200600512A (de)
HN (1) HN2008000906A (de)
HR (1) HRP20080319B1 (de)
IL (2) IL192088A (de)
IN (1) IN2008DE06112A (de)
MX (1) MX284326B (de)
MY (1) MY145870A (de)
NO (1) NO340818B1 (de)
NZ (1) NZ569186A (de)
PE (1) PE20070840A1 (de)
PL (1) PL1973561T3 (de)
PT (1) PT1973561E (de)
RU (1) RU2465005C2 (de)
SI (1) SI1973561T1 (de)
SV (1) SV2008002942A (de)
TW (2) TWI402039B (de)
UA (1) UA95266C2 (de)
WO (1) WO2007075343A2 (de)
ZA (1) ZA200805780B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GT200600512A (es) * 2005-12-15 2007-06-28 Enzimas para reducir el estres inmunologico
EP2814331B1 (de) * 2012-02-16 2018-12-05 Elanco US Inc. Verfahren und zusammensetzungen zur verringerung der umweltbelastung von tierexkrementen
ES2649217T3 (es) * 2013-07-26 2018-01-10 Novozymes A/S Polipéptidos que tienen actividad de alfa-L-galactosidasa y polinucleótidos que los codifican
WO2015140318A1 (en) * 2014-03-21 2015-09-24 Dsm Ip Assets B.V. Process for the treatment of yeast cell walls with a laminaripentaose producing beta-1,3-glucanase
CN106771257A (zh) * 2017-01-24 2017-05-31 北京美正生物科技有限公司 一种检测血清淀粉样蛋白a的酶联免疫吸附试剂盒及其制备方法和用途
CN107156522A (zh) * 2017-06-23 2017-09-15 都匀市山郎科技养殖有限公司 一种鸡饲料
BE1030865B1 (nl) * 2022-09-12 2024-04-09 Nu3Guts Bv Voederadditief voor het verbeteren van de darmgezondheid en/of de verteerbaarheid van voeder in vee
WO2025099136A2 (en) * 2023-11-10 2025-05-15 Kerry Group Services International Limited Nucleases in animal feed

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58201949A (ja) * 1982-05-17 1983-11-25 Kyodo Shiryo Kk 家畜用配合飼料
US5372939A (en) * 1991-03-21 1994-12-13 The United States Of America As Represented By The United States Department Of Energy Combined enzyme mediated fermentation of cellulous and xylose to ethanol by Schizosaccharoyces pombe, cellulase, β-glucosidase, and xylose isomerase
JP2942384B2 (ja) * 1991-06-07 1999-08-30 株式会社ヤクルト本社 飼料効率改善添加剤
GB2261877A (en) 1991-11-21 1993-06-02 Kyowa Hakko Kogyo Kk Animal feed additive comprising enzyme and amino acid
AU4835693A (en) * 1993-08-13 1995-03-14 Rijksuniversiteit Te Groningen Pharmaceutical composition comprising phosphatase or a derivative thereof
US5861271A (en) * 1993-12-17 1999-01-19 Fowler; Timothy Cellulase enzymes and systems for their expressions
DE69535721T2 (de) * 1994-04-22 2009-03-19 Novozymes A/S Verfahren zur Verbesserung von der Löslichkeit von pflanzlichen Proteinen
GB9416841D0 (en) * 1994-08-19 1994-10-12 Finnfeeds Int Ltd An enzyme feed additive and animal feed including it
NL1003096C2 (nl) 1995-05-15 1996-11-19 Gist Brocades Bv Application of phospholipases in animal feed.
JP2001057852A (ja) * 1995-06-14 2001-03-06 Showa Denko Kk 耐熱酵素含有飼料用組成物
US5807694A (en) * 1995-09-07 1998-09-15 Economic Innovation And Technology Council, University Of Manitoba Detection of salmonella enteritidis and other pathogenic microorganisms and monoclonal antibody useful therefor
CN1201373A (zh) * 1995-11-06 1998-12-09 诺沃挪第克公司 动物饲料添加剂
EP0904359A1 (de) * 1996-04-12 1999-03-31 Novo Nordisk A/S Enzym mit -g(b)-1,3-glucanase aktivitaet
CN1092495C (zh) 1996-05-03 2002-10-16 开姆根有限公司 半纤维素酶在低热焓饲料中的应用
US6162473A (en) * 1996-05-03 2000-12-19 Chemgen Corporation Hemicellulase use in feeds with low caloric content
US20020164751A1 (en) * 1996-06-19 2002-11-07 Short Jay M. Enzymes having thermostable phosphatase activity and methods of use thereof
GB9623539D0 (en) * 1996-11-12 1997-01-08 Biotal Ltd Enzymes and their use
GB2327345B (en) 1997-07-18 1999-06-23 Finnfeeds Int Ltd Use of an enzyme for manufacturing an agent for controlling bacterial infection
US6022566A (en) * 1997-12-02 2000-02-08 Balchem Corporation Method for increasing the feed intake, feed efficiency, daily gain and/or carcass grade in ruminants
EP0976838A1 (de) * 1998-05-06 2000-02-02 Rhone-Poulenc Nutrition Animale Enzymgemisch
US6331426B1 (en) * 1999-02-11 2001-12-18 Novozymes A/S Bacterial galactanases and use thereof
US6213930B1 (en) 1999-03-15 2001-04-10 Wisconsin Alumni Research Foundation Method of using anti-phospholipase A2 antibodies to enhance growth or improve feed efficiency
US6500658B1 (en) * 1999-08-17 2002-12-31 Novozymes, A/S Xyloglucanase from Malbranchea
UA78486C2 (uk) 1999-12-10 2007-04-10 Хемджен Корпорейшн Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти)
GB0010748D0 (en) 2000-05-05 2000-06-28 Brown Paul D Tricep exercise horse (fold up and portable)
US20020095135A1 (en) * 2000-06-19 2002-07-18 David Meeker Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases
GB2371013B (en) 2001-01-16 2004-06-09 Terry John Claydon Copying apparatus
JP2004526431A (ja) * 2001-01-17 2004-09-02 ラモト アット テル アヴィヴ ユニヴァーシティ リミテッド 食虫植物に由来するキチナーゼ、該キチナーゼをコードするポリヌクレオチド配列、ならびに該キチナーゼを単離および使用する方法
DE10105306A1 (de) * 2001-02-02 2002-08-22 Nutrinova Gmbh Futtermittel für die Nutztieraufzucht enthaltend Sorbinsäure und Enzyme
DE10105347A1 (de) * 2001-02-05 2002-08-22 Nutrinova Gmbh Sorbinsäurepräparat enthaltend Probiotika als Futtermittelzusatz in der Nutztieraufzucht
IE20011100A1 (en) * 2001-12-21 2003-07-09 Vsl Pharma Ltd Analytical Method for Detecting Alkaline Sphingomyelinase and Kit for Use in Such Method
WO2003062409A2 (en) 2002-01-25 2003-07-31 Dsm Ip Assets B.V. Thermostable enzyme compositions
AU2003304239A1 (en) * 2002-11-13 2005-01-13 Yvonne J. Rosenberg A pretreatment or post exposure treatment for exposure to a toxic substance by pulmonary delivery (inhaler) of a bioscavenger
AU2003298036A1 (en) * 2002-12-12 2004-07-09 Zoltan Laboratories Placental alkaline phosphatase to control diabetes
AU2005210581B2 (en) * 2004-02-04 2010-06-24 Am-Pharma B.V. Use of alkaline phosphatase for the detoxification of LPS present at mucosal barriers
US20110142817A1 (en) * 2004-02-04 2011-06-16 Pharmaaware Sepsis B.V. Means and method for treating and/or preventing necrotizing enterocolitis
PL1740204T3 (pl) * 2004-04-01 2018-08-31 Chiesi Farmaceutici S.P.A. Lecznicze zastosowanie alfa-mannozydazy
MX2007011631A (es) * 2005-03-25 2007-11-22 Univ Gent Desmetilacion enzimatica de favonoides.
CN1699576A (zh) * 2005-06-30 2005-11-23 江南大学 一种内切β－1,3葡聚糖酶基因及其克隆方法
EP1931332A4 (de) * 2005-09-12 2010-06-23 Zoltan Lab Llc Verbindungen und zusammensetzungen zur kontrolle von anomalem zellwachstum
GT200600512A (es) * 2005-12-15 2007-06-28 Enzimas para reducir el estres inmunologico
US8784805B2 (en) * 2008-02-29 2014-07-22 Alloksys Life Sciences B.V. Method for increasing the activity of the immune system of a mammal at risk of inflammatory diseases

Also Published As

Publication number Publication date
AR057247A1 (es) 2007-11-21
NO340818B1 (no) 2017-06-26
US8778648B2 (en) 2014-07-15
US20110171344A1 (en) 2011-07-14
NO20083035L (no) 2008-09-11
CN102293323A (zh) 2011-12-28
US20110171345A1 (en) 2011-07-14
HRP20080319B1 (hr) 2015-11-20
CL2011000941A1 (es) 2014-08-08
TW200731932A (en) 2007-09-01
KR20130082514A (ko) 2013-07-19
US7914782B2 (en) 2011-03-29
IL192088A (en) 2013-07-31
EP1973561A2 (de) 2008-10-01
JP2009519712A (ja) 2009-05-21
HRP20080319A2 (hr) 2008-12-31
TWI619506B (zh) 2018-04-01
EP2263685A3 (de) 2011-04-06
SI1973561T1 (sl) 2011-07-29
KR101399205B1 (ko) 2014-05-27
AU2006329927B2 (en) 2011-09-29
CN101374544A (zh) 2009-02-25
SV2008002942A (es) 2008-12-03
WO2007075343A2 (en) 2007-07-05
UA95266C2 (uk) 2011-07-25
TWI402039B (zh) 2013-07-21
IL227318A (en) 2016-11-30
US20110177195A1 (en) 2011-07-21
IL192088A0 (en) 2009-02-11
ES2361819T3 (es) 2011-06-22
US20070141041A1 (en) 2007-06-21
EP1973561B1 (de) 2011-02-09
JP5189989B2 (ja) 2013-04-24
RU2465005C2 (ru) 2012-10-27
CR10116A (es) 2008-10-28
TW201336425A (zh) 2013-09-16
ZA200805780B (en) 2009-03-25
GT200600512A (es) 2007-06-28
NZ569186A (en) 2011-09-30
CN105831428B (zh) 2020-12-01
PL1973561T3 (pl) 2011-08-31
DK1973561T3 (da) 2011-05-23
MY145870A (en) 2012-05-15
US20170156371A1 (en) 2017-06-08
KR101454032B1 (ko) 2014-10-27
CA2633066C (en) 2015-01-20
BRPI0620155B1 (pt) 2015-07-21
MX2008007735A (en) 2008-08-27
EP2263685A2 (de) 2010-12-22
CA2633066A1 (en) 2007-07-05
ECSP088578A (es) 2008-10-31
WO2007075343A3 (en) 2007-10-04
KR20080081972A (ko) 2008-09-10
RU2008128583A (ru) 2010-01-20
MX284326B (en) 2011-03-01
PT1973561E (pt) 2011-05-12
BRPI0620155A2 (pt) 2011-11-01
AU2006329927A1 (en) 2007-07-05
CN101374544B (zh) 2016-05-18
IN2008DE06112A (de) 2008-09-26
CN105831428A (zh) 2016-08-10
HN2008000906A (es) 2011-07-12
DE602006020074D1 (de) 2011-03-24
PE20070840A1 (es) 2007-08-25

Similar Documents

Publication Publication Date Title
DK1737974T3 (da) Fremgangsmåder til identifikation af proteiner med stivelsesphosphorylerende enzymatisk aktivitet
DK1848718T3 (da) E1 aktiveringsenzymhæmmere
EP1969123A4 (de) Neue enzyme
DE602005022454D1 (de) Enzymatische nachweistechniken
DK1926393T3 (da) Phytaseholdigt enzymgranulat
IL190988A0 (en) Novel highly functional enzyme having modified substrate-specificity
ZA200805780B (en) Enzymes for reduced immunological stress
EP1859035A4 (de) Immobilisierte enzyme
EP1767204A4 (de) Lipase-inhibitoren
FI20055692L (fi) Uusia entsyymejä
DE502005000305D1 (de) Photobioreaktor
DK1907567T3 (da) Forbedrede ekstraktionsfremgangsmåder og assay til fødevareenzymer
EP1915443A4 (de) Immobilisierte enzyme und verwendungsverfahren dafür
DK1657303T3 (da) Fremgangsmåde til at fremstille et immobiliseret enzym
DE112006001407A5 (de) Neues Fermentationsverfahren
DE602006018034D1 (de) Enzymherstellungsverfahren
BRPI0818162A2 (pt) Métodos enzimáticos e enzimas
DE602005014475D1 (de) Nukleinsäure/enzym-komplex
AU2012201152B2 (en) Novel lipase
DK1910527T3 (da) Maltose-1-phosphat producerende enzym
GB0506074D0 (en) Improved enzyme assay
FIU20100336U0 (fi) Entsyymirakeet
FIU20100337U0 (fi) Entsyymirakeet
DK1937808T3 (da) Forbedring af enzymproduktion
GB0526169D0 (en) Enzyme inhibitors

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1973561

Country of ref document: EP